Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 August 2026 - 15:19

Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-18-2020

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters